Daxor PE Ratio 2010-2011 | DXR
Current and historical p/e ratio for Daxor (DXR) from 2010 to 2011. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Daxor PE ratio as of May 30, 2025 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Daxor PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2025-05-30 | 8.10 | 0.00 | |
| 2011-12-31 | 8.59 | $-1.69 | 0.00 |
| 2011-09-30 | 9.87 | $-0.81 | 0.00 |
| 2011-06-30 | 9.51 | $0.80 | 11.89 |
| 2011-03-31 | 9.45 | $0.88 | 10.73 |
| 2010-12-31 | 8.52 | $1.17 | 7.29 |
| 2010-09-30 | 7.96 | $0.29 | 27.44 |
| 2010-06-30 | 8.51 | $0.29 | 29.34 |
| 2010-03-31 | 9.44 | $1.71 | 5.52 |
| 2009-12-31 | 10.09 | $1.37 | 7.37 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Outpatient & Home Care | $0.039B | $0.000B |
| Daxor Corporation is a medical device manufacturing corporation with additional biotech services. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quest Diagnostics (DGX) | United States | $19.201B | 18.92 |
| Encompass Health (EHC) | United States | $12.097B | 25.64 |
| DaVita (DVA) | United States | $10.293B | 14.47 |
| Chemed (CHE) | United States | $8.385B | 26.35 |
| Elanco Animal Health (ELAN) | United States | $6.715B | 14.38 |
| Option Care Health (OPCH) | United States | $5.282B | 23.55 |
| RadNet (RDNT) | United States | $4.141B | 262.81 |
| Amedisys (AMED) | United States | $3.083B | 20.74 |
| LifeStance Health (LFST) | United States | $2.298B | 0.00 |
| Addus HomeCare (ADUS) | United States | $2.082B | 22.85 |
| Astrana Health (ASTH) | United States | $1.367B | 33.86 |
| U.S Physical Therapy (USPH) | United States | $1.148B | 29.65 |
| Aveanna Healthcare Holdings (AVAH) | United States | $1.024B | 58.33 |
| Pennant (PNTG) | United States | $0.967B | 35.51 |
| Atai Life Sciences (ATAI) | Germany | $0.465B | 0.00 |
| MEDIROM Healthcare Technologies (MRM) | Japan | $0.041B | 0.00 |
| Ontrak (OTRK) | United States | $0.006B | 0.00 |
| Psychemedics (PMD) | United States | $0.000B | 0.00 |